Hypothesis

CLOCK protein, independent of its transcriptional circadian function, maintains limbal epithelial progenitor identity by stabilizing heterochromatin at the PAX6 locus, thereby preventing age‑associated stem cell exhaustion.

Mechanistic Rationale

1. Heterochromatin scaffolding – In mesenchymal stem cells, CLOCK overexpression (even a transcriptionally dead mutant) reinforces heterochromatin architecture and delays senescence [1]. We propose that CLOCK directly binds nucleosome‑dense regions flanking the PAX6 promoter/enhancer and recruits the H3K9 methyltransferase SUV39H1, increasing H3K9me3 marks that lock PAX6 in a poised, progenitor‑specific chromatin state.

2. Circadian modulation of CLOCK activity – Cellular NAD+ levels oscillate with the circadian rhythm and regulate SIRT1‑mediated deacetylation of CLOCK. Acetylated CLOCK has higher chromatin affinity; during the subjective day, elevated NAD+ activates SIRT1, deacetylating CLOCK and reducing its heterochromatin‑binding capacity, allowing a permissive window for PAX6 transcription and transient differentiation. At night, re‑acetylation restores CLOCK‑driven heterochromatin reinforcement, preserving the progenitor pool.

3. Stem cell outcome – When circadian desynchrony flattens NAD+ oscillations, CLOCK remains predominantly deacetylated, leading to chronic heterochromatin over‑compaction at PAX6, suppressing its expression and impairing progenitor proliferation (as seen in PAX6 deficiency) [2,3]. Conversely, loss of CLOCK abolishes this protective heterochromatin buffer, accelerating limbal stem cell senescence and corneal epithelial thinning.

Testable Predictions

• Prediction 1: In young murine limbal epithelium, CLOCK chromatin immunoprecipitation (ChIP‑seq) will show enriched binding at PAX6-associated heterochromatic peaks, coinciding with high H3K9me3 levels.
• Prediction 2: Pharmacological elevation of NAD+ (e.g., with NMN) will increase SIRT1 activity, reduce CLOCK acetylation, decrease CLOCK‑PAX6 binding, and transiently up‑regulate PAX6 mRNA without altering total CLOCK protein levels.
• Prediction 3: Limbal epithelial cultures from aged mice transfected with a transcriptionally inert CLOCK mutant will rescue PAX6 expression, increase colony‑forming efficiency, and reduce senescence‑associated β‑galactosidase activity compared with vector controls.
• Prediction 4: CRISPR‑interference targeting the CLOCK‑binding motif within the PAX6 heterochromatic region will phenocopy CLOCK loss: diminished H3K9me3, PAX6 down‑regulation, and impaired wound‑healing in ex vivo corneal organ culture.

Falsifiability

If any of the above predictions fail—for example, if CLOCK does not bind PAX6 chromatin, if NAD+ manipulation does not alter CLOCK acetylation or PAX6 dynamics, or if transcriptionally dead CLOCK fails to rejuvenate aged limbal progenitors—the hypothesis that CLOCK‑mediated heterochromatin stabilization directly safeguards PAX6+ limbal stem cells would be refuted, prompting a reassessment of circadian proteins’ role in ocular stem cell aging.

Broader Impact

Confirming this link would reposition the circadian clock as an epigenetic gatekeeper of tissue‑specific stemness, offering a novel avenue to combat age‑related corneal blindness by targeting NAD+/SIRT1‑CLOCK heterochromatin axes rather than relying solely on transcriptional clock agonists.